Sept 19 (Reuters) - Perrigo Co said it received final approval from U.S. health regulators for Ciclopirox topical solution, a generic version of Sanofi-Aventis' Penlac nail-fungus treatment. The ...
We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. These striking hues had our nails looking chicer than ever Alyssa Brascia is a ...
Co announces that it has received final approval from the FDA to manufacture and market Ciclopirox Topical Solution, 8%. Shipments will begin immediately. The product has been determined to be ...
Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycoses 1989;32:609-19. Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback